AlphaYouMR
Insider selling
Michael R Megna sold $309K of Kiniksa Pharmaceuticals International, plc (KNSA) stock
Michael R Megna, Chief Accounting Officer of Kiniksa Pharmaceuticals International, plc (KNSA), sold 6,625 shares of KNSA stock worth $309K, per an SEC Form 4 filed Apr 13, 2026.
It was an open-market sale.
The trade happened on Apr 9, 2026, 4 days before it was made public.
KNSA has moved +65.1% since the trade date, from $47.33 to $78.13 (Sep 21, 2026 close).
- Traded
- Apr 9, 2026
- Disclosed
- Apr 13, 2026
- Filing delay
- 4 days
- Price since
- +65.1%
- Role
- Chief Accounting Officer
- Source
- SEC Form 4
More KNSA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.